Bill Conkling

Bill Conkling serves as the Chief Commercial Officer at Protara Therapeutics since June 2025. Previously, Bill held the position of President and Chief Executive Officer at Rafael Holdings, Inc. from March 2021 to May 2025 and also served as Chief Commercial and Business Officer during that time. Additionally, Bill was a Member of the Board of Directors at Cyclo Therapeutics, Inc. from May 2023 to March 2025. Bill's extensive experience includes a role as Vice President of Sales, Marketing, Market Access, and Commercial Operations at Immunomedics from May 2018 to March 2021, and as Vice President, Global Commercial Head of CAR-T at Novartis Oncology from May 2013 to May 2018, where Bill led the global launch of CTL019, Novartis' first CAR-T therapy. Bill's educational background includes a Master of Business Administration from NYU Stern School of Business and a Bachelor of Science in Economics from Fordham University.